Surrogate markers to monitor efficacy of anticoagulants or antiplatelet drugs in atrial fibrillation.
Jilma
B
B
D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D015415:Biomarkers / Q000097:blood; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use*; D001620:beta-Thromboglobulin / Q000032:analysis
D000925:Anticoagulants; D015415:Biomarkers; D005338:Fibrin Fibrinogen Degradation Products; D010975:Platelet Aggregation Inhibitors; D001620:beta-Thromboglobulin; C036309:fibrin fragment D; D014859:Warfarin